© 2024 © 2020 Genprex Inc. All Rights Reserved.
Company achieves major milestones in clinical development programs in 2022
Patient treatment in Acclaim-2 clinical trial commences
Major milestones achieved in advancing gene therapies for lung cancer and diabetes